期刊文献+

FHIT蛋白在宫颈癌中的表达及临床意义 被引量:2

Expression of FHIT and Clinical Significance in Cervix Carcinoma
下载PDF
导出
摘要 为探讨 FHIT的表达与宫颈癌临床病理指标及预后之间的关系 ,应用免疫组化方法检测 5 0例宫颈癌和 2 0例正常宫颈组织中 FHIT蛋白的表达。结果显示 ,5 0例宫颈癌中 ,2 7例显示 FHIT蛋白表达降低或缺失 ,FHIT表达的降低或缺失与肿瘤的组织学分级 (P=0 .0 0 2 )和淋巴结转移 (P=0 .0 16)明显相关 ;FHIT表达阳性者和阴性者的 3年生存率分别为 83 .3 %和 5 2 .2 % ,差异有显著性 (P=0 .0 3 7)。 The aim of this study was to investigate the expression of FHIT and their relationship with clinicopathologic parameters and prognosis in cervix carcinoma. Immunohistochemical analysis was performed in 50 invasive cervix carcinomas and 20 normal cervix tissues. Twenty seven tumors exhibited loss of FHIT expression. Loss of FHIT protein correlated significantly with histological grade( P =0.002) and lymph node metastasis( P =0.016). The 3-year survival for patients whose tumors displays positive FHIT expression versus negative FHIT expression was 83.3% versus 52.2%, respectively. There was statistical diffrence between them( P =0.037).
出处 《数理医药学杂志》 2004年第3期216-218,共3页 Journal of Mathematical Medicine
关键词 FHIT蛋白 宫颈癌 预后 免疫组化 检测 Cervix carcinoma FHIT Immunohistochemistry
  • 相关文献

参考文献8

  • 1Ji L, Fang B, Yen N, et al. Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression. Cancer Res,1999, 59: 3333~3339.
  • 2Disaia PJ, Creasman WT. Clinical Gynecologic Oncology. 5th..st. Louis: Mosby, Inc. 1997: 85-99.
  • 3Ohta M, Inoue H, Cotticelli MG,et al. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renel carcinoma-associated t(3; 8) breakpoint,is abnormal in digestive tract cancers. Cell,1996, 84: 587-597.
  • 4Sard L, Accornero P, Tornielli S, et al. The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control. Proc Natl Acad Sci USA, 1999, 96: 8489-8492.
  • 5Greenspan DL,Connolly DC. Rong W, et al. Loss of FHIT expression in cervical carcinoma cell lines and primary tumors. Cancer Res,1997, 57: 4692-4698.
  • 6Birrer MJ, Hendricks D, Farley J, et al. Abnormal Fhit expression in malignant and premalignant lesions of the cervix. Cancer Res, 1999, 59: 5270-5274.
  • 7Krivak TC, Mcbroom JW, Seidman J, et al. Abnormal FHIT expression in advanced cervical carcinoma: a poor prognostic factor.Cancer Res, 2001, 61: 4382-4385.
  • 8Baykal C, Ayhan A, Al A, et al. No relationship is indicated between FHIT expression and clinicopathologic prognostic parameters in early stage cervical carcinoma. Int J Gynecol Cancer, 2003,13: 192-196.

同被引文献10

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部